Financial News Archive

SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s

Hikma
FDA Approves BUPRENORPHINE AND NALOXONE — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. announced the approval of its buprenorphine and naloxone sublingual product, strengthening the company’s presence in th...

Lannett
FDA Approves CODEINE SULFATE — Lannett Company, Inc.

Lannett Company, Inc. announced the approval of its Abbreviated New Drug Application (ANDA 203046) for generic codeine sulfate tablets, positioning th...

Breckenridge
FDA Approves DULOXETINE DELAYED-RELEASE — Breckenridge Pharmaceutical, Inc.

Breckenridge Pharmaceutical, Inc. has secured a new FDA approval for the generics of Duloxetine Hydrochloride, a revenue-generating asset that is set ...

Amneal
FDA Approves OXYCODONE HYDROCHLORIDE — Amneal Pharmaceuticals LLC

Amneal Pharmaceuticals secured FDA approval for the generic formulation of oxycodone hydrochloride, positioning the company to act as a price suppress...

Takeda
FDA Approves ENTYVIO — Takeda Pharmaceuticals America, Inc.

# FDA Approves Takeda's ENTYVIO for Inflammatory Bowel Disease Takeda Pharmaceuticals America, Inc. received FDA approval for ENTYVIO (vedolizumab), ...

ACTAVIS
FDA Approves Unknown Drug — ACTAVIS LABS FL INC

**ACTAVIS LABS FL INC** has announced that the FDA has approved **[Substance]** under ANDA **202144**. The approval is expected to immediately bolster...

Solco
FDA Approves IRBESARTAN AND HYDROCHLOROTHIAZIDE — Solco Healthcare US, LLC

# FDA Approves Generic Irbesartan and Hydrochlorothiazide from Solco Healthcare Solco Healthcare US, LLC has received FDA approval for a generic form...

Nova
FDA Approves MERCAPTOPURINE — Nova Laboratories, Ltd

Nova Laboratories has received FDA approval for the oral formulation of mercaptopurine (NDA205919), expanding an existing treatment portfolio during t...

SENORES
FDA Approves Unknown Drug — SENORES PHARMS

Senores Pharma secured FDA approval for its generic product, a move that is expected to bolster the company’s revenue stream while introducing immedia...

TORRENT
FDA Approves Unknown Drug — TORRENT

TORRENT Pharmaceuticals announced that the FDA has approved its Abbreviated New Drug Application (ANDA) 200160 for [insert specific drug substance/pro...

Aurobindo
FDA Approves TRAMADOL HYDROCHLORIDE — Aurobindo Pharma Limited

Aurobindo Pharma Limited announced the approval of its ANDA (No. 203494) for Tramadol Hydrochloride tablets, heightening competition in the generic pa...

MYLAN
FDA Approves Unknown Drug — MYLAN

Mylan received FDA approval on March 20 to market the generic version of this product, a move that is poised to allow the company to capitalize on pea...

Lantheus
FDA Approves NEURACEQ — Lantheus Biosciences Ltd., a Lantheus company

Lantheus Biosciences has received FDA approval of NEURACEQ® (florbetaben F 18), a molecular imaging agent indicated for the detection of amyloid plaqu...

McKesson
FDA Approves LIDOCAINE HYDROCHLORIDE — McKesson Corporation dba SKY Packaging

McKesson Corporation dba SKY Packaging announced the FDA approval of generic lidocaine hydrochloride (ANDA 204494), a topical solution widely used for...

Upsher-Smith
FDA Approves TOPIRAMATE — Upsher-Smith Laboratories, LLC

# FDA Approves Upsher-Smith's Topiramate Oral Formulation Upsher-Smith Laboratories, LLC received FDA approval for its oral topiramate formulation (N...

NorthStar
FDA Approves SPIRONOLACTONE — NorthStar Rx LLC

NorthStar Rx LLC announced on Friday that its ANDA approval of the oral generic version of SPIRONOLACTONE has been granted by the FDA, marking a new e...

Lupin
FDA Approves DOXYCYCLINE — Lupin Pharmaceuticals, Inc.

Lupin Pharmaceuticals, Inc. secured FDA approval on March 5, 2014, for its generic Doxycycline oral tablets, positioning the company to capture market...

Heritage
FDA Approves TRANEXAMIC ACID — Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc.

Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. has received FDA approval for the ANDA202436 for tranexamic acid, strengthening its port...

Washington
FDA Approves AMMONIA N 13 — Washington University School of Medicine

# FDA Approval Newswire Washington University School of Medicine has received FDA approval for AMMONIA N-13 (NH3N13), an intravenous diagnostic radio...

SANKALP
FDA Approves Unknown Drug — SANKALP LIFECARE

Sankalp Lifecare announced FDA approval for its new drug application, a milestone that is expected to diversify the company's revenue streams and stre...